Fermentalg

Regulatory Filings • Jun 20, 2016

Press release

Optimized process book for DHA production is completed at Libourne

Libourne – 20 June 2016 – Fermentalg, an industrial biotechnology company that specializes in the production of oils and proteins derived from microalgae, is pleased to announce the publication of its optimized process book for DHA production. Completed in the company's scientific facilities in Libourne, this last stage in pre-industrialization opens the way for large-scale production.

Andrew Echatti, Chief Executive Officer, said: "The publication of our optimized DHA process book is a major milestone that will enable us to concretely meet our industrial production targets. The fact that we were able to deliver this document to ARD just weeks after signing our agreement is further proof of Fermentalg's scientific expertise and our capacity to mobilize the resources we need to work in project mode on an industrial scale. The company is proud to be able to demonstrate its ability to uphold its commitments. Congratulations to the Fermentalg teams whose hard work made this success possible."

The new and optimized process book was finalized after several production cycles using the fermenters at Libourne. The tests were carried out by simulating real production conditions and using scientific data and ISO and NF approved controls much like those used to obtain the company's European Novel Food Authorization. The close to 200-page process book will serve as the basis for large-scale production, in particular at ARD's industrial site.

As a reminder, Fermentalg and ARD, a company specializing in bio-refining, industrial biotechnologies and bio-based chemistry, announced the signing of an industrial agreement for the large-scale production of DHA in May.

DHA, an essential fatty acid from the Omega-3 family which is known for its role in the prevention of numerous illnesses, is highly sought-after in human nutrition. It is recognized for its beneficial effects on the brain (tissue, healthy development and increase in intellectual capacity) and the heart (reduction in triglycerides, cholesterol and the risk of cardiovascular disease).

By completing the optimized process book on time, Fermentalg has confirmed its ambition to market this new source of DHA between now and the end of the year.

About Fermentalg

Founded in 2009 by Pierre Calleja, Fermentalg is an industrial biotechnology company that specializes in producing sustainable oils and proteins derived from the exceptional properties of microalgae. Its patented technology allows it to target a range of fast-growing global markets, from nutrition and animal feed to cosmetics and health. Fermentalg has already signed its 1st jointventure for the production of Omega-3 oils rich in DHA. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at: www.fermentalg.com.

Press Relations: Investor Relations:

ACTUS finance & communication Alexandra Prisa Tel: +33 (0)1 53 67 36 90 aprisa@actus.fr

ACTUS finance & communication Jérôme Fabreguettes-Leib Tel: +33 (0)1 53 67 36 78 jfl@actus.fr